- TLSI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
TriSalus Life Sciences (TLSI) S-1IPO registration
Filed: 14 Jun 24, 6:16am
Exhibit 107
Calculation of Filing Fee Tables
S-1
(Form Type)
TriSalus Life Sciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered
| | | | | | | | |
| Security | Security | Fee | Amount | Proposed | Maximum | Fee Rate | Amount of |
Newly Registered Securities | ||||||||
Fees to | Equity | Common Stock, | 457(c) | 130,805(2) | $6.345(3) | $829,957.73 | $0.00014760 | $122.51 |
| Total Offering Amounts | | $829,957.73 | | $122.51 | |||
| Total Fees Previously Paid | | | | — | |||
| Total Fee Offsets | | | | — | |||
| Net Fees Due | | | | $122.51 |
(1) | Includes an indeterminable number of additional securities that, pursuant to Rule 416 under the Securities Act of 1933, as amended, may be issued to prevent dilution from stock splits, stock dividends or similar transactions that could affect the Common Stock to be offered by the selling securityholder. |
(2) | Represents 130,805 shares of Common Stock issuable upon the exercise of private warrant at an exercise price of $9.5662per share of Common Stock. |
(3) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sales price of the Registrant’s shares of Common Stock as reported on the Nasdaq Stock Market on June 10, 2024. |